NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
N/A (NSE: INDIQUBE)
INDIQUBE Technical Analysis
5
As on 8th Aug 2025 INDIQUBE SHARE Price closed @ 216.05 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 7.28 & Strong Buy for SHORT-TERM with Stoploss of 30.83 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INDIQUBESHARE Price
Open | 201.00 | Change | Price | % |
High | 220.24 | 1 Day | 16.10 | 8.05 |
Low | 201.00 | 1 Week | -1.67 | -0.77 |
Close | 216.05 | 1 Month | -1.92 | -0.88 |
Volume | 1387359 | 1 Year | -1.92 | -0.88 |
52 Week High 218.42 | 52 Week Low 199.95 |
NSE N/A Most Active Stocks
NSE N/A Top Gainers Stocks
MIRCELECTR | 20.37 | 19.61% |
KRBL | 427.90 | 15.07% |
DMCC | 336.35 | 12.79% |
PREMIERPOL | 50.65 | 10.93% |
PARASPETRO | 2.46 | 9.82% |
MUKANDLTD | 136.20 | 9.82% |
SANGHVIMOV | 307.70 | 9.09% |
GVPTECH | 9.81 | 8.52% |
KMSUGAR | 28.35 | 8.45% |
RATEGAIN | 474.00 | 7.91% |
NSE N/A Top Losers Stocks
NESTLEIND | 1096.50 | -50.93% |
PGEL | 588.80 | -20.09% |
OSWALAGRO | 76.13 | -10.83% |
KALYANKJIL | 528.10 | -10.64% |
GILLANDERS | 119.24 | -10.12% |
BESTAGRO | 453.75 | -10.00% |
DATAMATICS | 989.25 | -8.72% |
IZMO | 378.25 | -7.90% |
KUANTUM | 115.13 | -7.84% |
VARROC | 510.95 | -7.78% |
INDIQUBE Daily Charts |
INDIQUBE Intraday Charts |
Whats New @ Bazaartrend |
INDIQUBE Free Analysis |
|
INDIQUBE Important Levels Intraday
RESISTANCE | 253.13 |
RESISTANCE | 241.24 |
RESISTANCE | 233.89 |
RESISTANCE | 226.54 |
SUPPORT | 205.56 |
SUPPORT | 198.21 |
SUPPORT | 190.86 |
SUPPORT | 178.97 |
INDIQUBE Target August 2025
4th UP Target | 259.15 |
3rd UP Target | 245.94 |
2nd UP Target | 237.78 |
1st UP Target | 229.62 |
1st DOWN Target | 206.32 |
2nd DOWN Target | 198.16 |
3rd DOWN Target | 190 |
4th DOWN Target | 176.79 |
INDIQUBE Weekly Target
4th UP Target | 279.19 |
3rd UP Target | 259.48 |
2nd UP Target | 247.29 |
1st UP Target | 235.11 |
1st DOWN Target | 200.33 |
2nd DOWN Target | 188.15 |
3rd DOWN Target | 175.96 |
4th DOWN Target | 156.25 |
INDIQUBE Target2025
4th UP Target | 259.15 |
3rd UP Target | 245.94 |
2nd UP Target | 237.78 |
1st UP Target | 229.62 |
1st DOWN Target | 206.32 |
2nd DOWN Target | 198.16 |
3rd DOWN Target | 190 |
4th DOWN Target | 176.79 |
N/A ( NSE N/A Symbol : INDIQUBE )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
INDIQUBE Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
INDIQUBE Other Details
Segment | N/A | |
Market Capital | N/A | |
Sector | N/A | |
Industry | N/A | |
Offical website | > echo $website ; ?> |
INDIQUBE Address
![]() |
N/A |
INDIQUBE Latest News
INDIQUBE Business Profile
N/A
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service